Selective Signaling by Akt1 Controls Osteoblast Differentiation and Osteoblast-Mediated Osteoclast Development

REFERENCES

• Abu-Amer Y, et al. 2000. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J. Biol. Chem. 275: 27307–27310.
   PubMed Web of Science ®Google Scholar
• Blair HC, Schlesinger PH, Huang CL, Zaidi M. 2007. Calcium signalling and calcium transport in bone disease. Subcell. Biochem. 45: 539–562.
   PubMedGoogle Scholar
• Brazil DP, Yang ZZ, Hemmings BA. 2004. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29: 233–242.
   PubMed Web of Science ®Google Scholar
• Buzzi F, et al. 2010. Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. Mol. Cell. Biol. 30: 601–612.
   PubMed Web of Science ®Google Scholar
• Chin YR, Toker A. 2010. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol. Cell 38: 333–344.
   PubMed Web of Science ®Google Scholar
• Cho H, et al. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728–1731.
   PubMed Web of Science ®Google Scholar
• Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. 2001. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276: 38349–38352.
   PubMed Web of Science ®Google Scholar
• DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ. 2006. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J. Biol. Chem. 281: 32841–32851.
   PubMedGoogle Scholar
• Ducy P, Karsenty G. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15: 1858–1869.
   PubMed Web of Science ®Google Scholar
• Easton RM, et al. 2005. Role for Akt3/protein kinase Bγ in attainment of normal brain size. Mol. Cell. Biol. 25: 1869–1878.
   PubMed Web of Science ®Google Scholar
• Feng X, McDonald JM. 2011. Disorders of bone remodeling. Annu. Rev. Pathol. 6: 121–145.
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury N, et al. 2002. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J. Biol. Chem. 277: 33361–33368.
   PubMed Web of Science ®Google Scholar
• Greenblatt MB, et al. 2010. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J. Clin. Invest. 120: 2457–2473.
   PubMed Web of Science ®Google Scholar
• Hanada R, Hanada T, Sigl V, Schramek D, Penninger JM. 2011. RANKL/RANK-beyond bones. J. Mol. Med. (Berl.) 89: 647–656.
   PubMed Web of Science ®Google Scholar
• Henriksen K, Bollerslev J, Everts V, Karsdal MA. 2011. Osteoclast activity and subtypes as a function of physiology and pathology—implications for future treatments of osteoporosis. Endocr. Rev. 32: 31–63.
   PubMed Web of Science ®Google Scholar
• Irie HY, et al. 2005. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171: 1023–1034.
   PubMed Web of Science ®Google Scholar
• Kawamura N, et al. 2007. Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS One 2: e1058.
   PubMed Web of Science ®Google Scholar
• Khosla S, Westendorf JJ, Oursler MJ. 2008. Building bone to reverse osteoporosis and repair fractures. J. Clin. Invest. 118: 421–428.
   PubMed Web of Science ®Google Scholar
• Kwak HB, et al. 2008. Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum. 58: 1332–1342.
   PubMed Web of Science ®Google Scholar
• Liu H, et al. 2006. Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. Proc. Natl. Acad. Sci. U. S. A. 103: 4134–4139.
   PubMed Web of Science ®Google Scholar
• Liu X, et al. 2007. Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc. Natl. Acad. Sci. U. S. A. 104: 2259–2264.
   PubMedGoogle Scholar
• Manning BD, Cantley LC. 2007. AKT/PKB signaling: navigating downstream. Cell 129: 1261–1274.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Irie N. 2008. Osteoclast-osteoblast communication. Arch. Biochem. Biophys. 473: 201–209.
   PubMed Web of Science ®Google Scholar
• Matsushita T, et al. 2009. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol. Cell. Biol. 29: 5843–5857.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Rotwein P. 2009. Akt promotes BMP2-mediated osteoblast differentiation and bone development. J. Cell Sci. 122: 716–726.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Rotwein P. 2008. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol. Endocrinol. 22: 1238–1250.
   PubMedGoogle Scholar
• Mukherjee A, Wilson EM, Rotwein P. 2010. Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation. Mol. Cell. Biol. 30: 1018–1027.
   PubMed Web of Science ®Google Scholar
• Novack DV, Teitelbaum SL. 2008. The osteoclast: friend or foe? Annu. Rev. Pathol. 3: 457–484.
   PubMed Web of Science ®Google Scholar
• Osyczka AM, Leboy PS. 2005. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146: 3428–3437.
   PubMed Web of Science ®Google Scholar
• Peng XD, et al. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17: 1352–1365.
   PubMed Web of Science ®Google Scholar
• Raggatt LJ, Partridge NC. 2010. Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 285: 25103–25108.
   PubMed Web of Science ®Google Scholar
• Raucci A, Bellosta P, Grassi R, Basilico C, Mansukhani A. 2008. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J. Cell. Physiol. 215: 442–451.
   PubMedGoogle Scholar
• Severyn CJ, Rotwein P. 2010. Conserved proximal promoter elements control repulsive guidance molecule c/hemojuvelin (Hfe2) gene transcription in skeletal muscle. Genomics 96: 342–351.
   PubMedGoogle Scholar
• Smoum R, et al. 2010. Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc. Natl. Acad. Sci. U. S. A. 107: 17710–17715.
   PubMedGoogle Scholar
• Somanath PR, Kandel ES, Hay N, Byzova TV. 2007. Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J. Biol. Chem. 282: 22964–22976.
   PubMed Web of Science ®Google Scholar
• Sugatani T, Hruska KA. 2005. Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J. Biol. Chem. 280: 3583–3589.
   PubMed Web of Science ®Google Scholar
• Teti A, et al. 1991. Osteoblast-osteoclast relationships in bone resorption: osteoblasts enhance osteoclast activity in a serum-free co-culture system. Biochem. Biophys. Res. Commun. 179: 634–640.
   PubMedGoogle Scholar
• Thrash BR, Menges CW, Pierce RH, McCance DJ. 2006. AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J. Biol. Chem. 281: 12155–12162.
   PubMed Web of Science ®Google Scholar
• Tournay O, Benezra R. 1996. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol. Cell. Biol. 16: 2418–2430.
   PubMed Web of Science ®Google Scholar
• Tu Q, et al. 2011. Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J. Biol. Chem. 286: 12542–12553.
   PubMed Web of Science ®Google Scholar
• Vandoorne K, et al. 2010. Bone vascularization and trabecular bone formation are mediated by PKB alpha/Akt1 in a gene-dosage-dependent manner: in vivo and ex vivo MRI. Magn. Reson. Med. 64: 54–64.
   PubMedGoogle Scholar
• Wilson EM, Hsieh MM, Rotwein P. 2003. Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J. Biol. Chem. 278: 41109–41113.
   PubMedGoogle Scholar
• Wilson EM, Rotwein P. 2007. Selective control of skeletal muscle differentiation by Akt1. J. Biol. Chem. 282: 5106–5110.
   PubMedGoogle Scholar
• Woodgett JR. 2005. Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 17: 150–157.
   PubMed Web of Science ®Google Scholar
• Wu X, et al. 2010. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7: 571–580.
   PubMedGoogle Scholar
• Yoeli-Lerner M, et al. 2005. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20: 539–550.
   PubMed Web of Science ®Google Scholar
• Zaidi M. 2007. Skeletal remodeling in health and disease. Nat. Med. 13: 791–801.
   PubMed Web of Science ®Google Scholar
• Zhou GL, et al. 2006. Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J. Biol. Chem. 281: 36443–36453.
   PubMed Web of Science ®Google Scholar